Next Article in Journal
Insecticidal and Nematicidal Activities of Novel Mimosine Derivatives
Previous Article in Journal
pH-Dependence of the Aqueous Phase Room Temperature Brønsted Acid-Catalyzed Chemoselective Oxidation of Sulfides with H2O2
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 20
Issue 9
10.3390/molecules200916723
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Anti-Oxidant, Anti-Aging, and Anti-Melanogenic Properties of the Essential Oils from Two Varieties of Alpinia zerumbet

by
Pham Thi Be Tu
1 and
Shinkichi Tawata
2,*
1
Department of Bioscience and Biotechnology, The United Graduate School of Agricultural Sciences, Kagoshima University, Korimoto 1-21-24, Kagoshima 890-0065, Japan
2
Department of Bioscience and Biotechnology, Faculty of Agriculture, University of the Ryukyus, Senbaru 1, Nishihara-cho, Okinawa 903-0129, Japan
*
Author to whom correspondence should be addressed.
Molecules 2015, 20(9), 16723-16740; https://doi.org/10.3390/molecules200916723
Submission received: 13 August 2015 / Revised: 3 September 2015 / Accepted: 10 September 2015 / Published: 14 September 2015
(This article belongs to the Section Medicinal Chemistry)
Browse Figures
Versions Notes

Abstract

:
Here, we investigated the anti-oxidant and anti-aging effects of essential oils (EOs) from the leaves of Alpinia zerumbet (tairin and shima) in vitro and anti-melanogenic effects in B16F10 melanoma cells. The anti-oxidant activities were performed with 2,2-diphenyl-1-picrylhydrazyl (DPPH); 2,2ʹ-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS); nitric oxide; singlet oxygen; hydroxyl radical scavenging; and xanthine oxidase. The inhibitory activities against collagenase, elastase, hyaluronidase, and tyrosinase were employed for anti-aging. The anti-melanogenic was assessed in B16F10 melanoma cells by melanin synthesis and intracellular tyrosinase inhibitory activity. The volatile chemical composition of the essential oil was analyzed with gas chromatography-mass spectrometry (GC/MS). The EO was a complex mixture mainly consisting of monoterpenes and sesquiterpenes. The results revealed that tairin and shima EOs showed strong anti-oxidant activities against DPPH and nitric oxide, hydroxyl radical scavenging activity, and xanthine oxidase inhibition. Compared to shima EO; tairin EO exhibited strong anti-aging activity by inhibiting collagenase, tyrosinase, hyaluronidase, and elastase (IC50 = 11 ± 0.1; 25 ± 1.2; 83 ± 1.6; and 213 ± 2 μg/mL, respectively). Both EOs inhibited intracellular tyrosinase activity; thus, reducing melanin synthesis. These results suggest that tairin EO has better anti-oxidant/anti-aging activity than shima EO, but both are equally anti-melanogenic.

Graphical Abstract

1. Introduction

Melanin, the major skin pigment, plays a crucial role in protecting human skin against ultraviolet (UV) radiation. However, overproduction and accumulation of melanin can result in pigmented patches and skin discolorations such as melasma, freckles, post-inflammatory melanoderma, and solar lentigo [1]. Melanin biosynthesis is regulated by melanogenesis enzymes, such as tyrosinase, which catalyzes two different reactions. In the initial step of melanin synthesis, l-tyrosine is hydroxylated to l-3,4-dihydroxyphenylalanine (l-DOPA, O-diphenol product). l-DOPA is oxidized further to the corresponding O-quinone. Thus, tyrosinase is an important regulator and the rate-limiting enzyme for melanogenesis [2]. Tyrosinase also regulates the browning of vegetables and foods. Therefore, melanin synthesis and tyrosinase inhibitors are used commonly in food processing and in cosmetics for melanin hyperpigmentation and skin whitening. Moreover, skin disorders are associated with increased dermal enzymatic activity, including collagenase, hyaluronidase, elastase, and tyrosinase [3,4,5,6]. Thus, inhibitors of these enzymes are increasingly important ingredients in cosmetics and medications to protect the skin against hyperpigmentation and skin aging.
UV radiation exposure induces formation of excess reactive oxygen species (ROS), which can interact with proteins, lipids, and DNA, and alter cellular functions, thus causing aging-related disorders or melanogenesis [7,8]. Recently, melanogenesis has been reported to produce hydrogen peroxide and other ROS in melanocytes [9]. This observation has increased interest in identifying natural antioxidants that inhibit skin aging and melanogenesis.
Alpinia zerumbet (Pers.) Burtt and Smith (alpinia), a member of the Zingiberaceae family, is a perennial plant that is distributed widely in subtropical and tropical regions and is used in folk medicine. In Okinawa, there are two varieties of alpinia, tairin (Alpinia zerumbet (Pers.) B. L. Burtt & R. M. Sm. var. excelsa Funak & T. Y. Ito) and shima (Alpinia zerumbet (Pers.) B. L. Burtt & R. M. Sm.). Tairin is a taller plant with long stems, whereas shima is shorter with a bushy structure. The leaves of both plants are used in the preparation of a traditional food, mu-chi, and are thought to prevent common cold [10].
We previously demonstrated that alpinia leaves have anti-oxidant and anti-microbial activities [11,12]. We also reported that alpinia can inhibit advanced glycation end products, HIV-1 integrase, and neuraminidase (NA) [13,14]. Essential oils (EO) from alpinia also have been reported to have various biological activities such as a myorelaxant and anti-spasmodic agent in the rat ileum [15], anti-nociceptive in mice [16], and anti-hypertensive and cardiovascular disease preventative in rats [17]. In addition, alpinia EOs are associated with anti-microbial and larvicidal activity [18,19].
In this study, we examined the anti-oxidant and anti-aging activity of EOs isolated from the leaves of two varieties of alpinia. Furthermore, we evaluated the inhibitory activity of these samples against melanin biosynthesis in B16F10 melanoma cells.

2. Results and Discussion

2.1. Chemical Compositions of Tairin and Shima EOs

The major compounds in the tairin EO were γ-terpinene (14.5%), cineole (13.8%), p-cymene (13.5%), sabinene (12.5%), terpinen-4-ol (11.9%), caryophyllene oxide (4.96%), methyl cinnamate (4.24%), caryophyllene (2.4%), and γ-terpineol (1.28%). Whereas shima EO contained the main components of cineole (37.8%), β-linalool (17.1%), caryophyllene oxide (10.4%), methyl cinnamate (6.34%), benzylacetone (4.21%), and α-terpineol (3.36%). The chemical components of the essential oil from two varieties of alpinia leaf were presented in Table 1.
Table
Table 1. Chemical components of the EO from two varieties of alpinia leaf.
Table 1. Chemical components of the EO from two varieties of alpinia leaf.
No.CompoundRetention IndexPeak Area (%)
TairinShima
1m-Cumenol9170.160.15
2α-Thujene9294.12-
3α-Pinene9342.02-
4Norborndadiene9430.08-
5Camphene9470.22-
6Benzaldehyde963-1.59
7Sabinene97412.5-
8β-Pinene9763.15-
9Myrcene9890.69-
10α-Phellandrene10020.31-
11p-Cymene102413.5-
121,8-Cineole103113.837.8
13γ-Terpinene105914.5-
14cis-β-Terpineol10680.55-
15β-Linalool11000.5017.1
162,5-Norbornadiene1111-0.71
17cis-p-Menth-2-en-1-ol11210.59-
18Borneol11540.310.11
19Terpinen-4-ol117311.9-
20γ-Terpineol11931.283.36
21trans-p-Menth-1-en-3-ol12060.42-
22Methyl cinnamate12334.246.32
23Benzylacetone12370.064.21
24Piperitone12480.030.1
25Bornyl acetate12800.37-
26Cumic alcohol12870.18-
272-tert-Butylphenyl pivalate1299-1.23
28Ethyl-3-hydroxy-3-methylbutanote1302-0.09
29Isopiperitenon1306-0.18
30Thymol13170.05-
312-Hydroxy-3,5-dimethylcyclopent-2-en-1-one1319-0.13
32p-Menth-1,4-dien-7-ol13240.07-
33Cymen-8-ol13540.260.29
34Carvacrol13791.611.89
35Caryophyllene14112.40-
362,6-Diethylnitrosobenzene1426-0.69
37α-trans-Bergamoene14280.09-
38Aristole-9-ene14340.15-
39α-Humulene14460.38-
40p-Cymen-7-ol14471.661.77
41γ-Cadinene15050.42-
42α-Bulnesene15140.25-
43Nerolidol15590.38-
44Caryophyllene oxide16804.9610.4
45α-Zingiberene17010.02-
Total98.1888.12

2.2. Anti-Oxidant Activities

2.2.1. DPPH and ABTS Radical Scavenging Activities

The scavenging activity of tairin and shima EOs was determined using 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radicals (Table 2). The results indicate that tairin EO exhibited higher antioxidant activity (IC50 = 5.7 ± 0.6 μg/mL) than shima EO (IC50 = 126 ± 1.1 μg/mL). The DPPH radical scavenging activity of tairin EO was also higher than that of the positive control, tert-butyl hydroxytoluene (BHT) (IC50 = 29 ± 0.6 μg/mL).
The scavenging capacity of tairin and shima EOs was also assessed using the 2,2ʹ-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) radical cation. The data indicate that the ABTS scavenging activity differed considerably between the EOs. The ABTS radical scavenging activity of tairin EO (IC50 = 260 ± 1.8 μg/mL) was greater than that of shima EO (IC50 = 337 ± 2.1 μg/mL) (Table 2).
Table
Table 2. Antioxidant activity of tairin and shima essential oils (EOs).
Table 2. Antioxidant activity of tairin and shima essential oils (EOs).
SampleAnti-Oxidant Activities (IC50, μg/mL)
DPPHABTSNitric OxideSinglet OxygenHydroxyl Radical Scavenging
Tairin5.7 ± 0.6 a260.5 ± 1.8 b66.3 ± 1.6 b2145 ± 2.8 c69.2 ± 2.1 a
Shima126.3 ± 1.1 c337.1 ± 2.1 c704.2 ± 1.4 c503 ± 1.7 b74.0 ± 1.2 b
BHT29.1 ± 0.6 b45.7 ± 1.7 a---
Ascorbic acid--14.4 ± 0.8 a-72.3 ± 1.2 b
Rutin---54.0 ± 0.2 a-
The values represent the mean ± standard error (n = 3). Letters with different superscripts indicate samples that are significant different (p < 0.05) to each other. IC, inhibitory concentration; DPPH, 2,2-diphenyl-1-picrylhydrazyl; ABTS, 2,2ʹ-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt; BHT, tert-butyl hydroxytoluene. (-): not detected.

2.2.2. Singlet Oxygen Scavenging (1O2) Activity

1O2 is a high-energy state molecular oxygen species. It is one of the most active intermediates involved in chemical and biochemical reactions. The singlet oxygen scavenging activity of tairin and shima EOs was compared with that of rutin (Table 2). Shima EO showed significantly (p < 0.05) higher 1O2 scavenging activity (IC50 = 503 ± 1.7 μg/mL) than tairin EO (IC50 = 2145 ± 2.8 μg/mL).

2.2.3. Hydroxyl and Nitric Oxide Radical Scavenging Activities

The hydroxyl radical scavenging activity of tairin and shima EOs was determined as the percent inhibition of hydroxyl radical formation in the Fenton reaction. The scavenging activity of tairin and shima EOs was compared with that of ascorbic acid. Tairin EO (IC50 = 69 ± 2.0 μg/mL) had significantly higher (p < 0.05) hydroxyl radical scavenging activity and was more potent than ascorbic acid (IC50 = 72 ± 1.2 μg/mL), whereas shima EO had an IC50 = 74 ± 1.2 μg/mL (Table 2).
Nitric oxide, generated from sodium nitroprusside in aqueous solutions, interacts with oxygen to produce nitrite ions, which can be measured by the Griess reaction. The EOs from tairin and shima showed scavenging activity between 66 and 704 μg/mL. The percent inhibition increased with increasing concentrations of EO. Tairin EO inhibited nitric oxide formation better (IC50 = 66 ± 1.6 μg/mL) than shima EO (IC50 = 704 ± 1.5 μg/mL) (Table 2). However, ascorbic acid inhibited nitric oxide better than both EOs, with an IC50 value of 14 ± 0.8 μg/mL.

2.3. Anti-Aging Activities

2.3.1. Collagenase and Elastase Assay

As shown in Figure 1A,B, the EOs from shima and tairin inhibited collagenase and elastase activities. Both tairin and shima EOs showed strong collagenase inhibitory activities (IC50 = 11 ± 0.1 μg/mL and 38 ± 0.4 μg/mL, respectively). Further, tairin EO inhibited collagenase better than the positive control, oleanolic acid (IC50 = 21 ± 0.2 μg/mL). A similar profile was observed when evaluating elastase activity. Tairin EO showed higher inhibitory activity (IC50 = 212 ± 2.1 μg/mL) than shima EO (IC50 = 322 ± 0.5 μg/mL).

2.3.2. Tyrosinase and Hyaluronidase Inhibition Assay

Tyrosinase is a multifunctional, glycosylated, copper-containing oxidase that catalyzes the first two steps of mammalian melanogenesis and is responsible for enzymatic browning reactions in damaged fruits during post-harvest handling and processing. In this study, we evaluated ability of EOs from tairin and shima to inhibit tyrosinase. Tairin EO (IC50 = 25 ± 1.2 μg/mL) inhibited tyrosinase better than shima EO (IC50 = 28 ± 1.5 μg/mL). However, kojic acid inhibited tyrosinase better than both EOs (IC50 = 10 ± 0.7 μg/mL) (Figure 2A).
The hyaluronidases are a group of enzymes distributed throughout the animal kingdom. In recent years, hyaluronidase has received attention owing to its ability to regulate hyaluronan metabolism. Hyaluronidase inhibitors are potent regulators that maintain hyaluronidase homeostasis and may serve as anti-inflammatory agents. Our results indicate that tairin EO is a stronger inhibitor (IC50 = 83 ± 1.6 μg/mL) of hyaluronidase than shima EO (IC50 = 150 ± 0.8 μg/mL) (Figure 2B).
Molecules 20 16723 g001 550
Figure 1. Tairin and shima essential oil (EO)-mediated collagenase (A) and elastase (B) inhibition. Values shown represent the mean ± standard error from three independent experiments. One-way ANOVA was used for the comparison of multiple group means, followed by the Duncan test (p < 0.05). Letters with different superscripts indicate samples that are significantly different (p < 0.05) from each other. IC, inhibitory concentration.
Figure 1. Tairin and shima essential oil (EO)-mediated collagenase (A) and elastase (B) inhibition. Values shown represent the mean ± standard error from three independent experiments. One-way ANOVA was used for the comparison of multiple group means, followed by the Duncan test (p < 0.05). Letters with different superscripts indicate samples that are significantly different (p < 0.05) from each other. IC, inhibitory concentration.
Molecules 20 16723 g001
Molecules 20 16723 g002 550
Figure 2. Tairin and shima essential oil (EO)-mediated tyrosinase (A) and hyaluronidase (B) inhibition. Values shown represent the mean ± standard error from three independent experiments. One-way ANOVA was used for the comparison of multiple group means, followed by the Duncan test (p < 0.05). Letters with different superscripts indicate samples that are significantly different (p < 0.05) from each other. IC, inhibitory concentration.
Figure 2. Tairin and shima essential oil (EO)-mediated tyrosinase (A) and hyaluronidase (B) inhibition. Values shown represent the mean ± standard error from three independent experiments. One-way ANOVA was used for the comparison of multiple group means, followed by the Duncan test (p < 0.05). Letters with different superscripts indicate samples that are significantly different (p < 0.05) from each other. IC, inhibitory concentration.
Molecules 20 16723 g002

2.3.3. Xanthine Oxidase Inhibition Assay

Xanthine oxidase is a flavoprotein that catalyzes the oxidation of hypoxanthine to xanthine and generates superoxide and uric acid. Xanthine oxidase inhibitors may be useful for the treatment of skin aging and gout, which is caused by the generation of uric acid and the superoxide anion radical. Our results indicate that tairin EO significantly inhibits xanthine oxidase (IC50 = 70 ± 0.6 μg/mL) and is a stronger inhibitor than shima EO (IC50 = 86 ± 0.4 μg/mL) (Figure 3).
Molecules 20 16723 g003 550
Figure 3. Inhibition of xanthine oxidase activity by tairin and shima essential oils (EOs). Values shown represent the mean ± standard error from three independent experiments. One-way ANOVA was used for the comparison of multiple group means, followed by the Duncan test (p < 0.05). Letters with different superscripts indicate samples that are significant different (p < 0.05) from each other. IC, inhibitory concentration.
Figure 3. Inhibition of xanthine oxidase activity by tairin and shima essential oils (EOs). Values shown represent the mean ± standard error from three independent experiments. One-way ANOVA was used for the comparison of multiple group means, followed by the Duncan test (p < 0.05). Letters with different superscripts indicate samples that are significant different (p < 0.05) from each other. IC, inhibitory concentration.
Molecules 20 16723 g003

2.4. Anti-Melanogenic Effects of Tairin and Shima EOs

2.4.1. Cell Viability

To analyze the effects of tairin and shima EOs on cell viability, B16F10 melanoma cells were treated with varying concentrations of EO for 48 h. As shown in Figure 4, the tairin and shima EOs did not affect the cell viability up to 50 μg/mL; however, treatment with 100 μg/mL caused a 26% ± 3% and 30% ± 3% decrease in cell viability, respectively. Thus, the tairin and shima EOs were used at concentrations up to 50 μg/mL to evaluate their effects on melanin content and intracellular tyrosinase activity.
Molecules 20 16723 g004 550
Figure 4. Effect of tairin and shima essenetial oils (EOs) on B16F10 melanoma cell viability. B16F10 cells were treated with various concentrations of EO and incubated for 48 h. Values shown represent the mean ± standard error for three independent experiments. One-way ANOVA was used for the comparison of multiple group means, followed by the Duncan test (p < 0.05). Letters with different superscripts indicate samples that are significantly different (p < 0.05) from each other.
Figure 4. Effect of tairin and shima essenetial oils (EOs) on B16F10 melanoma cell viability. B16F10 cells were treated with various concentrations of EO and incubated for 48 h. Values shown represent the mean ± standard error for three independent experiments. One-way ANOVA was used for the comparison of multiple group means, followed by the Duncan test (p < 0.05). Letters with different superscripts indicate samples that are significantly different (p < 0.05) from each other.
Molecules 20 16723 g004

2.4.2. Effects of Tairin and Shima EOs on Melanin Content

To determine the anti-melanogenic activity of tairin and shima EOs, their effect on melanin content was evaluated in B16F10 melanoma cells. The B16F10 melanoma cells were treated with varying concentrations of tairin and shima EOs and then stimulated with IBMX for 48 h. As shown in Figure 5, tairin and shima EOs dose-dependently inhibited melanin content. At 50 μg/mL, melanin synthesis was inhibited 55% ± 6% and 48% ± 7%, respectively. Kojic acid, the positive control, inhibited melanin content 54% ± 7%. These results demonstrated that both tairin and shima EOs decreased the melanin content without any effect on the cell viability.
Molecules 20 16723 g005 550
Figure 5. Effect of tairin and shima essential oils (EOs) on melanin production in B16F10 melanoma cells. B16F10 cells were treated with various concentrations of EO and incubated for 48 h. The melanin content of B16F10 melanoma cells was measured with a microplate reader at 490 nm. Values shown represent the mean ± standard error for three independent experiments. A one-way ANOVA was used for the comparison of multiple group means, followed by the Duncan test (p < 0.05). Letters with different superscripts indicate samples that are significant different (p < 0.05) from each other.
Figure 5. Effect of tairin and shima essential oils (EOs) on melanin production in B16F10 melanoma cells. B16F10 cells were treated with various concentrations of EO and incubated for 48 h. The melanin content of B16F10 melanoma cells was measured with a microplate reader at 490 nm. Values shown represent the mean ± standard error for three independent experiments. A one-way ANOVA was used for the comparison of multiple group means, followed by the Duncan test (p < 0.05). Letters with different superscripts indicate samples that are significant different (p < 0.05) from each other.
Molecules 20 16723 g005

2.4.3. Inhibition of the Intracellular Tyrosinase Activity by Tairin and Shima EOs

To evaluate whether tairin and shima EOs inhibit the intracellular tyrosinase activity, the B16F10 melanoma cells were treated with varying concentrations of the EOs for 48 h, followed by incubation with l-DOPA. Our data indicate that, following treatment with 20 μg/mL tairin and shima EOs, tyrosinase activity was inhibited by 41% ± 1% and 31% ± 6%, respectively. At a concentration of 50 μg/mL, both tairin EO (72% ± 1%) and shima EO (71% ± 1%) inhibited tyrosinase activity more potently than that by the positive control kojic acid (49% ± 3%) (Figure 6). These results indicate that tairin and shima EOs could be applicable in cosmetics as skin-whitening agents for the treatment of pigmentation disturbances.
Molecules 20 16723 g006 550
Figure 6. Effect of tairin and shima essential oils (EOs) on intracellular tyrosinase activity in B16F10 melanoma cells. B16F10 cells were treated with various concentrations of EO and incubated for 48 h. The intracellular tyrosinase activity of B16F10 melanoma cells was measured with a microplate reader at 490 nm. Values shown represent the mean ± standard error for three independent experiments. One-way ANOVA was used for the comparison of multiple group means, followed by the Duncan test (p < 0.05). Letters with different superscripts indicate samples that are significant different (p < 0.05) from each other.
Figure 6. Effect of tairin and shima essential oils (EOs) on intracellular tyrosinase activity in B16F10 melanoma cells. B16F10 cells were treated with various concentrations of EO and incubated for 48 h. The intracellular tyrosinase activity of B16F10 melanoma cells was measured with a microplate reader at 490 nm. Values shown represent the mean ± standard error for three independent experiments. One-way ANOVA was used for the comparison of multiple group means, followed by the Duncan test (p < 0.05). Letters with different superscripts indicate samples that are significant different (p < 0.05) from each other.
Molecules 20 16723 g006

2.5. Discussion

The safety of natural products used in drugs, health foods, and cosmetic ingredients is a major concern. Several studies have explored the use of extracts from the leaves of Aesculus hippocastanum and Bunge [20,21], the gel of Aloe vera [22], the oil of Camellia japonica L. [23], and the rhizomes of Zingiber officinale L. [24] to prevent skin abnormalities and hyperpigmentation. In this study, we first determined the free radical scavenging activities of tairin and shima EOs. Our study demonstrated that tairin had stronger anti-oxidant activity than shima, with the exception of singlet oxygen scavenging activity. The GC/MS analysis showed tairin and shima EOs contain the major components of monoterpenes and sesquiterpenes. Previous studies have been reported that monoterpenes, such as terpinen-4-ol, 1,8-cineol, and γ-terpinene, showed anti-oxidant activities [11,12,25,26]. The strong anti-oxidant activity from tairin and shima EOs may be attributed from these components. It is known that UV radiation induces free radical formation in the skin, which is linked directly to the onset of skin photodamage and biological damage. Thus, our results suggest that tairin and shima EOs may be useful anti-oxidant sources to prevent UV-induced damage.
Next, we highlighted the anti-aging activity of EOs from tairin and shima through collagenase, elastase, hyaluronidase, and tyrosinase enzyme inhibition assays, and compared these results with those of oleanolic acid, which is a skin-protective pentacyclic triterpene. UV light stimulates collagenase expression, which causes matrix protein degradation and, subsequently, skin photoaging [27]. Elastase and hyaluronidase are proteolytic enzymes in the dermis that are responsible for the degradation of elastin and hyaluronan, respectively, in the extracellular matrix. Loss of elastin is a major part of what cause visible signs of aging (wrinkles, sagging) in the skin. Additionally, in human melanocytes, melanin synthesis is regulated by tyrosinase, leading to skin diseases. Our results indicate that tairin EO was a stronger tyrosinase, elastase, and hyaluronidase inhibitor than shima EO.
To our knowledge, the inhibitory effect of tairin and shima EOs on melanogenesis is reported here for the first time. IBMX is a well-known stimulator of melanogenesis, leading to tyrosinase synthesis and increased melanin levels [28]. We found that the EOs decreased melanin content in melanoma cells more effectively than the commercial melanin synthesis inhibitor (kojic acid). In order to understand better the potential use of tairin and shima EOs to reduce melanogenesis, we also evaluated the inhibition of intracellular tyrosinase activity. The present study indicated that tairin and shima EOs strongly inhibited intracellular tyrosinase activity. Thus, these EOs may be good candidates for use in skin-whitening materials.
In addition, we previously found a few RAC/CDC42-activated kinase 1 (PAK1)-blocking compounds in extracts of alpinia [29] and recently have revealed that PAK1 is essential for melanogenesis as well as the aging process and oncogenesis [30,31]. Thus, it is most likely that the anti-aging and anti-melanogenic effects of alpinia EOs could be partly attributed to their PAK1-blocking activity.

3. Experimental Section

3.1. General

2,2-diphenyl-1-picrylhydrazyl (DPPH), tert-butyl hydroxytoluene (BHT), kojic acid, 2,2ʹ-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS), quercetin, l-tyrosine, hydrogen peroxide, sodium hypochloride, histidine, ion (III) chloride, potassium dihydrogen phosphate, hydrochloric acid, potassium hydroxide, Dulbecco’s modified Eagle medium (DMEM), fetal bovine serum (FBS), Triton-X, and bovine serum albumin (BSA) were purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). N-suc-(Ala)3-nitroanilide (SANA), N-[3-(2-furyl) acryloyl]-Leu-Gly-Pro-Ala (FALGPA), collagenase, elastase, hyaluronidase, tyrosinase, hyaluronic acid, oleanolic acid, sodium nitroprusside (SNP), N,N-dimethyl-4-nitrosoaniline (RNO), sulfanilic acid, trichloroacetic acid, thiobarbituric acid, ascorbic acid, 2-deoxy-2 ribose, l-tyrosine, l-DOPA, 3-(4,5-dimetylyhiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), dimethyl sulfoxide (DMSO), and N-(1-naphthy) ethyenediamine dihydrochloride (NED) were obtained from Sigma-Aldrich, Inc. (St. Louis, MO, USA). Xanthine was purchased from Kanto Chemical Co., Inc. (Tokyo, Japan). Xanthine oxidase was purchased from Toyobo Co., Ltd. (Osaka, Japan). Ethylenediaminetetraacetic acid (EDTA) was obtained from Kanto Chemical Co, Inc. (Tokyo, Japan). B16F10 melanoma cells were purchased from American Type Culture Collection (Rockville, MD, USA).

3.2. Extraction of EO from Alpinia Leaf

The EOs from fresh tairin and shima leaves (500 g) were isolated by steam distillation for 4 h. The distillate was extracted with diethyl ether, and the solvent was removed carefully under vacuum at 35 °C. The obtained EOs were dissolved in methanol and dimethyl sulfoxide (DMSO) and kept under refrigeration until use.

3.3. Gas Chromatography-Mass Spectrometry (GC-MS) Analysis

The compounds of EO were identified using DB-5MS fused silica capillary column (30 m × 0.25 mm i.d., 0.25 μm; Agilent Technologies, J & W Scientific Products, Folsom, CA, USA). The carrier gas was helium and the GC oven temperature program was as follows: 80 °C hold for 1 min, increase 10 °C/min to 220 °C, followed by increase to 330 °C at 20 °C/min and hold for 6 min. The injector and detector temperatures were set at 250 °C and 280 °C, respectively, and the injection volume was 1.0 μL in the splitless mode. Mass spectra were scanned form m/z 50–600 amu and the electron impact ionization energy was 70 eV. Quantitative determinations of EO components were done based on the peak area measurements. Retention indices were determined relative to the retention times of a series of n-alkane standards (C7 to C31, Restek Corporation, PA, USA), and compared with published values [11,12].

3.4. Anti-Oxidant Activity

3.4.1. DPPH Radical Scavenging Assay

The DPPH radical scavenging assay was performed according to Boskou et al. [32]. DPPH (40 μL) and sodium acetate buffer (80 μL, 0.1 M, pH 5.5) were added to samples (80 μL) containing a range of EO concentrations (10, 100, and 250 μg/mL). The mixture was incubated at room temperature in the dark for 30 min. The absorbance was measured at 517 nm using a microplate spectrophotometer (Bio-Rad Laboratories, Inc., Hercules, CA, USA). BHT was used as positive control.

3.4.2. ABTS Radical Scavenging Assay

The ABTS radical scavenging assay was carried out using a method previously described by Re et al. [33]. The working solution was prepared by mixing 7 mM ABTS and 2 mM K2S2O8 in equal quantities and allowing them to react in the dark overnight (more than 16 h) at room temperature. The solution was diluted with water to obtain an absorbance of 0.70 ± 0.03 units at 734 nm. The working ABTS solution (200 μL) was mixed with 20 μL of the samples containing varying EO concentrations (10, 100, and 250 μg/mL), and the absorbance was measured at 734 nm after 6 min of incubation at room temperature. BHT was used as a positive control.

3.4.3. Hydroxyl Radical Scavenging (•OH) Assay

The hydroxyl radical scavenging assay was performed as described by Ozyurek et al. [34]. The reaction mixture for the deoxyribose assay contained the following reagents in a final volume of 1 mL: 200 μL of KH2PO4-KOH (100 mM), 200 μL of deoxyribose (15 mM), 200 μL of FeCl3 (500 μM), 100 μL of EDTA (1 mM), 100 μL of ascorbic acid (1 mM), 100 μL of H2O2 (10 mM), and 100 μL of sample. The reaction mixtures were incubated at 37 °C for 1 h. At the end of the incubation period, 1 mL of 2.8% (w/v) trichloroacetic acid (TCA) was added to each mixture, followed by the addition of 1 mL of 1% (w/v) thiobarbituric acid (TBA). The solutions were heated in a water bath at 90 °C for 15 min until a pink color developed, and the absorbance of the resulting solution was measured at 532 nm. Ascorbic acid was used as a positive control.

3.4.4. Singlet Oxygen Scavenging (1O2) Assay

The production of singlet oxygen was determined by monitoring p-nitrosodimethylaniline (RNO) bleaching using a spectrophotometric method previously reported by Chakraborty and Tripathy [35]. Singlet oxygen was generated by reacting NaOCl and H2O2, and the bleaching of RNO was measured. The reaction mixture contained 45 mM phosphate buffer (pH 7.1), 50 mM NaOCl, 50 mM H2O2, 50 mM histidine, 10 μM RNO, and the test sample in a final volume of 2 mL. The reaction was incubated at 30 °C for 40 min, and the decrease in RNO absorbance was measured at 440 nm. Rutin was used as a positive control.

3.4.5. Nitric Oxide Scavenging Assay

Nitric oxide radical scavenging activity was estimated using the Griess Illosvoy reaction [36]. The reaction mixture (300 μL), containing 10 mM SNP (200 μL), phosphate-buffered saline (50 μL), and the test sample (50 μL), was incubated at 25 °C for 150 min. After incubation, 50 μL of the reaction mixture was mixed with 100 μL of sulfanilic acid reagent (0.33% in 20% glacial acetic acid) and allowed to stand for 5 min for complete diazotization. NED (100 μL) was added, and the mixture was incubated at 25 °C for 30 min, until a pink chromophore could be observed in diffused light. The absorbances of these solutions were measured at 540 nm against the corresponding blank solutions. Ascorbic acid was used as the positive control, while methanol was used as the control for calculation.
The % scavenging capacities of DPPH, ABTS, hydroxyl radical, singlet oxygen, and nitric oxide were calculated using the formula:
% scavenging capacity = [(Acontrol − Asample)/Acontrol] × 100
where Acontrol is the absorbance of the control without the test sample, and Asample is the absorbance of the sample.
All experiments were carried out in triplicate. The % radical scavenging activity was plotted against the corresponding extract concentration to obtain the IC50 value.

3.5. Enzymatic Activities

3.5.1. Collagenase Inhibition Assay

The collagenase inhibition assay was performed by measuring FALGPA hydrolysis using a previously described method [37]. The assay was performed in 50 mM tricine buffer, containing 400 mM NaCl and 10 mM CaCl2 (pH 7.5). Clostridium histolyticum collagenase (ChC) and the synthetic substrate, N-(3-[2-Furyl]acryloyl)-Leu-Gly-Pro-Ala (FALGPA) were dissolved in the tricine buffer for use at initial concentrations of 0.8 U/mL and 2 mM, respectively. The EOs was incubated with the enzyme in the buffer for 15 min before adding the substrate to start the reaction. The final reaction mixture (150 μL total volume) contained tricine buffer, 0.8 mM FALGPA, 0.1 U ChC, and 25 μg EO samples. Water and methanol were used as negative controls, while oleanolic acid was used as a positive control. After incubating with the substrate for 20 min, collagenase activity was measured at 340 nm.

3.5.2. Elastase Inhibition Assay

Elastase inhibition was assayed using the method of Kransoe et al. [38] with slight modifications. Inhibition was determined by measuring the intensity of the solution color following elastase-mediated SANA cleavage. Briefly, 1 mM SANA was prepared in 0.1 M Tris-HCl buffer (pH 8.0). The solution (200 μL) was added to a stock sample solution (20 μL). The solutions were vortexed and preincubated for 10 min at 25 °C, and then 20 μL of elastase from porcine pancreas (0.03 U/mL) was added. After vortexing, each solution was placed in a water bath at 25 °C for 10 min. The absorbance was measured at 410 nm. Negative controls were performed with water and methanol, while oleanolic acid was used as a positive control.

3.5.3. Hyaluronidase Inhibition Assay

Inhibition of hyaluronidase was determined as previously described [39]. A 5 μL test sample was pre-incubated with bovine hyaluronidase (1.50 U) in 100 μL of solution containing 20 mM (pH 7.0) sodium phosphate buffer, 77 mM sodium chloride, and 0.01% bovine serum albumin (BSA) for 10 min at 37 °C. The assay was initiated by adding 100 μL of hyaluronic acid sodium salt from rooster comb (0.03% in 300 mM sodium phosphate, pH 5.35) to the incubation mixture, followed by incubation for 45 min at 37 °C. Undigested hyaluronic acid was precipitated with acid albumin solution (1 mL), composed of 0.1% BSA in 24 mM sodium acetate and 79 mM acetic acid (pH 3.75). The solution was allowed to stand at room temperature for 10 min, and the absorbance was measured at 600 nm. Oleanolic acid was used as the positive control.
The percent collagenase, elastase, and hyaluronidase inhibition were calculated by:
Enzyme inhibition activity (%) = (1 − B/A) × 100
where A is the enzyme activity without sample, and B is the activity in the presence of the sample.

3.5.4. Tyrosinase Inhibition Assay

Tyrosinase inhibition was determined by measuring DOPA chrome formation as previously described [40]. In brief, EO samples were dissolved in solvent to varying concentrations (10, 100, and 250 μg/mL). Samples were prepared in a 96-well plate, and the components were added as follows: phosphate buffer (120 μL, 20 mM, pH 6.8), 20 μL sample, and 20 μL mushroom tyrosinase (500 U/mL in 20 mM phosphate buffer). After incubation at 25 °C for 15 min, the reaction was initiated by adding 20 μL l-tyrosine solution (0.85 mM) to each well and incubating at room temperature for 10 min. The enzyme activity was determined by measuring the absorbance at 470 nm. Kojic acid was used as the positive control. The percent tyrosinase inhibition was calculated as follows:
Tyrosinase inhibition (%) = [(A − B) − (C − D)]/(A − B) × 100
where A is the absorbance of the control with the enzyme, B is the absorbance of the control without the enzyme, C is the absorbance of the test sample with the enzyme, and D is the absorbance of the test sample without the enzyme.

3.5.5. Xanthine Oxidase Inhibition Assay

Xanthine oxidase activity was determined by measuring the formation of uric acid from xanthine [41]. Phosphate buffer (300 μL, 50 mM, pH 7.4) was used in this assay. Varying concentrations of EO (100 μL) were mixed with a solution containing xanthine oxidase (100 μL, 0.2 U/mL) and water (100 μL). Samples were then incubated at 37 °C for 15 min. Xanthine (200 μL, 0.15 mM) was then added to each sample and further incubated at 37 °C for 30 min. The reaction was stopped by adding HCl (200 μL, 0.5 M). The production of uric acid was determined by measuring the absorbance at 295 nm. The buffer was used as a blank, and the control was a solution containing xanthine and xanthine oxidase.
The percent xanthine oxidase inhibition was calculated by:
Enzyme inhibition activity (%) = (1 − B/A) × 100
where A is the enzyme activity without sample, and B is the activity in the presence of the sample.

3.6. Effects of Tairin and Shima EO on Melanin Biosynthesis in B16F10 Melanoma Cells

3.6.1. Cell Culture

B16F10 melanoma cells were cultured in DMEM supplemented with 10% heat-inactivated FBS and 1% penicillin/streptomycin (10,000 U/mL and 100 μg/mL) at 37 °C in a humidified atmosphere containing 5% CO2.

3.6.2. Cell Viability

Cell viability was determined after EO treatment using an MTT assay, as described by Campos et al. [42]. Briefly, B16F10 cells were plated at a density of 7 × 103 cells/well in a 96-well plate. After 48 h of culture, cells were exposed to varying concentrations of tairin and shima EOs (10, 50, and 100 μg/mL) or 500 μM kojic acid and incubated for an additional 48 h at 37 °C. Following incubation, the medium was removed, and the cells were washed twice with phosphate buffer and incubated with MTT solution (0.5 mg/mL) for 3 h at 37 °C. The medium was discarded, and 200 μL of ethanol was added. The absorbance of each well was measured at 570 nm using a microplate spectrophotometer (Bio-Rad Laboratories, Inc., Hercules, CA, USA).

3.6.3. Measurement of Melanin Content

Melanin content was determined as described by Yoon et al. [43]. In brief, B16F10 cells were plated at a density of 7 × 103 cells/well in a 96-well plate. After 48 h of culture, cells were exposed to varying concentrations of tairin and shima EO (10, 20, and 50 μg/mL) or 500 μM kojic acid. After 1 h, 100 μM isobutyl-1-methylxanthine (IBMX) was added, and cells were incubated for an additional 48 h at 37 °C. The cells were washed twice with phosphate buffer, and then dissolved in 100 μL NaOH (1 N) containing 10% DMSO. Samples were incubated at 80 °C for 1 h and mixed to solubilize the melanin. The optical density of the mixed homogenate was measured at 490 nm. To measure the amount of melanin in each experiment, the total amount of melanin (100%) produced during the experimental period was considered as the control group, and the rate of inhibition in the treatment groups was calculated in proportion to this standard.

3.6.4. Intracellular Tyrosinase Activity

Tyrosinase activity was determined as described by Li et al. [44] with slight modifications. B16F10 cells were plated at a density of 7 × 103 cells/well in a 96-well plate. After 48 h of culture, cells were exposed to varying concentrations of tairin and shima EO (10, 20, and 50 μg/mL) or 500 μM kojic acid. After 1 h, 100 μM isobutyl-1-methylxanthine (IBMX) was added, and the cells were incubated for an additional 48 h at 37 °C. The cells then were washed with ice-cold phosphate buffer and lysed with phosphate buffer (pH 6.8) containing 1% Triton-X (90 μL/well). The plates were frozen at −80 °C for 30 min. After thawing and mixing, 10 μL of 1% l-DOPA was added to each well. Following incubation at 37 °C for 2 h, the absorbance was measured at 490 nm.

3.7. Statistical Analysis

Each experiment was performed in triplicate. All data are presented as the mean ± SE. Statistical analysis was done by one-way analysis of variance (ANOVA) complemented by the Duncan test. Differences were considered significant when the p value was less than 0.05.

4. Conclusions

This report is the first to demonstrate the anti-aging, anti-oxidant, and anti-melanogenesis activities of EOs from tairin and shima in cell culture. The present study reveals that EOs from tairin and shima have strong anti-oxidant activities against DPPH, ABTS, nitric oxide, singlet oxygen, and the hydroxyl radical, and inhibit xanthine oxidase. Tairin EO is a stronger inhibitor against a series of aging enzymes, such as collagenase, tyrosinase, hyaluronidase, and elastase, than shima EO. Moreover, both tairin and shima EOs are anti-melanogenic.

Acknowledgments

We express sincere thanks to Hiroshi Maruta at the PAK Research Center, Okinawa, Japan, for his useful comments and suggestions. We also thank Oshiro Hana and all lab members for sample collection.

Author Contributions

Shinkichi Tawata provided the initial idea for research. Pham Thi Be Tu and Shinkichi Tawata designed the research. Pham Thi Be Tu conducted the experimental work and drafted the manuscript. Shinkichi Tawata edited the paper. All authors discussed and approved the final manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Kim, H.E.; Ishihara, A.; Lee, S.G. The effects of Caffeoylserotonin on inhibition of melanogenesis through the downregulation of MITF via the reduction of intracellular cAMP and acceleration of ERK activation in B16 murine melanoma cells. BMB Rep. 2012, 45, 724–729. [Google Scholar] [CrossRef]
  2. Jimenez-Cervantes, C.; Garcia-Borron, J.C.; Vanverde, P.; Solano, F.; Lozano, J.A. Tyrosinase isoenzymes in mammalian melanocytes. 1. Biochemical characterization of two melanosomal on tyrosinase from B16 mouse melanoma. Eur. J. Biochem. 1993, 217, 549–556. [Google Scholar] [CrossRef] [PubMed]
  3. Losso, J.N.; Munene, C.N.; Bansode, R.R.; Bawadi, H.A. Inhibition of matrix metalloproteinase-1 activity by the soybean Bowman-Birk inhibitor. Biotechnol. Lett. 2004, 26, 901–905. [Google Scholar] [CrossRef] [PubMed]
  4. Azmi, N.; Hashim, P.; Hashim, D.; Halimoon, N.; Muhamad, N.; Majid, N. Anti-elastase, anti-tyrosinase and matrix metalloproteinase-1 inhibitory activity of earthworm extracts as potential new anti-aging agent. Asian Pac. J. Trop. Biomed. 2014, 4, S348–S352. [Google Scholar] [CrossRef] [PubMed]
  5. Thring, T.S.A.; Hili, P.; Naughton, D.P. Anti-collagenase, anti-elastase and anti-oxidant activities of extracts from 21 plants. BMC Complement. Altern. Med. 2009, 9, 27. [Google Scholar] [CrossRef] [PubMed]
  6. Barla, F.; Higashijima, H.; Funai, S.; Sugimoto, K.; Harada, N.; Yamaji, R.; Fujita, T.; Nakano, Y.; Inui, H. Inhibitive effects of alkyl gallates on hyaluronidase and collagenase. Biosci. Biotechnol. Biochem. 2009, 73, 2335–2337. [Google Scholar]
  7. Wang, G.; Chen, K.; Chen, L.; Hu, C.; Zhang, D.; Liu, Y. The involvement of the antioxidant system in protection of desert cyanobacterium Nostoc sp. against UV-B radiation and the effects of exogenous antioxidants. Ecotoxicol. Environ. Saf. 2008, 69, 150–157. [Google Scholar] [CrossRef] [PubMed]
  8. Huang, H.C.; Lien, H.M.; Ke, H.J.; Chang, L.L.; Chen, C.C.; Chang, T.M. Antioxidative characteristics of Anisomeles indica extract and inhibitory effect of Ovatodiolode on melanogenesis. Int. J. Mol. Sci. 2012, 13, 6220–6235. [Google Scholar] [CrossRef] [PubMed]
  9. Yamakoshi, J.; Otsuka, F.; Sano, A.; Tokutake, S.; Saito, M.; Kikuchi, M.; Kubota, Y. Lightening effect on ultraviolet-induced pigmentation of guinea pig skin by oral administration of a proanthocyanidin-rich extract from grape seeds. Pigment Cells Res. 2003, 16, 629–638. [Google Scholar] [CrossRef]
  10. Tawata, S.; Fukuta, M.; Xuan, T.D.; Deba, F. Total utilization of tropical plants Leucaena leucocephala and Alpinia zerumbet. J. Pestic. Sci. 2008, 33, 40–43. [Google Scholar] [CrossRef]
  11. Elzaawely, A.A.; Xuan, T.D.; Koyama, H.; Tawata, S. Antioxidant activity and contents of essential oil and phenolic compounds in flowers and seeds of Alpinia zerumbet (Pers.) B.L. Burtt. & R.M. Sm. Food Chem. 2007, 104, 1648–1653. [Google Scholar]
  12. Elzaawely, A.A.; Xuan, T.D.; Tawata, S. Essential oils, kava pyrones and phenolic compounds from leaves of Alpinia zerumbet (Pers.) B.L. Burtt. & R.M. Sm. and their antioxidant activity. Food Chem. 2007, 103, 486–494. [Google Scholar]
  13. Chompoo, J.; Upadhyay, A.; Kishimoto, W.; Makise, T.; Tawata, S. Advanced glycation end products inhibitors from Alpinia zerumbet rhizomes. Food Chem. 2011, 129, 709–715. [Google Scholar] [CrossRef] [PubMed]
  14. Upadhyay, A.; Chompoo, J.; Kishimoto, W.; Makise, T.; Tawata, S. HIV-1 integrase and neuraminidase inhibitors from Alpinia zerumbet. J. Agric. Food Chem. 2011, 59, 2857–2862. [Google Scholar] [CrossRef] [PubMed]
  15. Bezerra, M.B.C.; Leal-Cardoso, J.H.; Coelho-de-Souza, A.N.; Criddle, D.N.; Fonteles, M.C. Myorelaxant and antispasmodic effects of the essential oil of Alpinia speciosa on rat ileum. Phytother. Res. 2000, 14, 549–551. [Google Scholar] [CrossRef]
  16. De Araújo, P.V.S.; Coelho-de-Souza, A.N.; Morais, S.M.; Ferreira, S.C.; Leal-Cardoso, J.H. Antinociceptive effects of the essential oil of Alpinia zerumbet on mice. Phytomedicine 2005, 12, 482–486. [Google Scholar] [CrossRef] [PubMed]
  17. Lahlou, S.; Interaminense, L.F.L.; Leal-Cardoso, J.H.; Duarte, G.P. Antihypertensive effects of the essential oil of Alpinia zerumbet and its main constituent, terpinen-4-ol, in DOCA-salt hypertensive conscious rats. Fundam. Clin. Pharmacol. 2003, 17, 323–330. [Google Scholar] [CrossRef] [PubMed]
  18. Victorio, C.P.; Alviano, D.S.; Alviano, C.S.; Lage, C.L.S. Chemical composition of the fractions of leaf oil of Alpinia zerumbet (Pers.) B.L. Burtt & R.M. Sm. and antimicrobial activity. J. Pharmacol. 2009, 19, 697–701. [Google Scholar]
  19. Cavalcanti, E.S.B.; de Morai, S.M.; Lima, M.A.A.; Sanata, E.W.P. Larvicidal activity of essential oils from Brazilian plants against Aedes aegypti L. Mem. Inst. Oswaldo Cruz 2004, 99, 541–544. [Google Scholar] [CrossRef] [PubMed]
  20. Fujimura, T.; Tsukahara, K.; Moriwaki, S.; Hotta, M.; Kitahara, T.; Takema, Y. A horse chestnut extract, which induces contraction forces in fibroblasts, is a potent anti-aging ingredient. J. Cosmet. Sci. 2006, 57, 369–376. [Google Scholar] [CrossRef] [PubMed]
  21. Hsu, M.F.; Chiang, B.H. Stimulating effects of Bacillus subtilis natto-fermented Radix astragali on hyaluronic acid production in human skin cells. J. Ethnopharmacol. 2009, 125, 474–481. [Google Scholar] [CrossRef] [PubMed]
  22. Jones, K.; Hughes, J.; Hong, M.; Jia, Q.; Orndorff, S. Modulation of melanogenesis by aloesin: A competitive inhibitor of tyrosinase. Pigment Cell Res. 2002, 15, 335–340. [Google Scholar] [CrossRef] [PubMed]
  23. Jung, E.; Lee, J.; Baek, J.; Jung, K.; Lee, J.; Huh, S.; Kim, S.; Koh, J.; Park, D. Effect of Camellia japonica oil on human type I procollagen production and skin barrier function. J. Ethnopharmacol. 2007, 112, 127–131. [Google Scholar] [CrossRef] [PubMed]
  24. Tsukahara, K.; Nagakawa, H.; Moriwaki, S.; Takema, Y.; Fujimura, T.; Imokawa, G. Inhibition of ultraviolet B-induced winkle formation by an elastase inhibiting herbal extract: Implication for the mechanism underlying elastase-associated winkles. Int. J. Dermatol. 2006, 45, 460–468. [Google Scholar] [CrossRef] [PubMed]
  25. Grassmann, J. Terpenoids as plant antioxidants. Vitam. Horm. 2005, 72, 505–535. [Google Scholar] [PubMed]
  26. Juergens, U.R.; Racke, K.; Tuleta, I.; Skowasch, D.; Stober, M.; Gillissen, A.; Nickenig, G. Antioxidative effects of monoterpenes (1,8-Cineol) compared with budesonide (BUD) on superoxide (O2−) production in human monocytes: New evidence for co-medication in COPD and sinusitis. Am. J. Respir. Crit. Care Med. 2009, 179, A4584. [Google Scholar] [CrossRef]
  27. Lee, Y.R.; Noh, M.; Kwon, K.B.; Lee, Y.S.; Chu, J.P.; Kim, E.J.; Park, Y.S.; Kim, B.S.; Kim, J.S. Radix clematidis extract inhibits UVB-induced MMP expression by suppressing the NF-κB pathway in human dermal fibroblasts. Int. J. Mol. Med. 2009, 23, 679–684. [Google Scholar] [PubMed]
  28. Lee, J.; Jung, E.; Park, J.; Jung, K.; Park, E.; Kim, J.; Hong, S.; Park, J.; Park, S.; Lee, S.; et al. Glycyrrhizin induces melanogenesis by elevating a cAMP level in B16 melanoma cells. J. Investig. Dermatol. 2005, 124, 405–411. [Google Scholar] [CrossRef] [PubMed]
  29. Nguyen, B.C.; Taira, N.; Tawata, S. Several herbal compounds in Okinawa plants directly inhibit the oncogenic/aging kinase PAK1. Drug Discov. Ther. 2014, 8, 238–244. [Google Scholar] [CrossRef] [PubMed]
  30. Maruta, H. Herbal therapeutics that block the oncogenic kinase PAK1: A practical approach towards PAK1-dependent diseases and longevity. Phytother. Res. 2014, 28, 656–672. [Google Scholar] [CrossRef] [PubMed]
  31. Be Tu, P.T.; Nguyen, B.C.Q.; Tawata, S.; Yun, C.Y.; Kim, E.G.; Maruta, H. PAK1, p21 (RAC/CDC42)-activated kinase 1, essential for melanogenesis in skin. J. Dermatol. Sci. 2015, in press. [Google Scholar]
  32. Boskou, G.; Salta, F.N.; Chrysotomou, S.; Mylona, A.; Chiou, A.; Andrikopoulos, N.K. Antioxidant capacity and phenolic profile of table olives from the Greek market. J. Food Chem. 2006, 94, 558–564. [Google Scholar] [CrossRef]
  33. Re, R.; Pellegrini, N.; Proteggente, A.; Pannala, A.; Yang, M.; Rice-Evans, C. Antioxidant activity applying an improved ABTS radical cation decolonization assay. J. Free Radic. Biol. Med. 1999, 26, 1231–1237. [Google Scholar] [CrossRef]
  34. Ozyurek, M.; Bektasoglu, B.; Guclu, K.; Apak, R. Hydroxyl radical scavenging assay of phenolics and flavonoids with a modified cupric reducing antioxidant capacity (CUPRAC) method using catalase for hydrogen peroxide degradation. Anal. Chim. Acta 2008, 616, 196–206. [Google Scholar] [CrossRef] [PubMed]
  35. Chakraborty, N.; Tripathy, B.C. Involvement of singlet oxygen in 5-aminolevulinic acid-induced photodynamic damage of cucumber (Cucumis sativus L.) chloroplasts. Plant Physiol. 1992, 98, 7–11. [Google Scholar] [CrossRef] [PubMed]
  36. Govindarajan, R.; Vijayakumar, M.; Rao, C.V.; Shirwaikar, A.; Rawat, A.K.S.; Mehrotra, S.; Pushpangadan, P. Antioxidant potential of Anogeissus latifolia. Biol. Pharm. Bull. 2004, 27, 1266–1269. [Google Scholar] [CrossRef] [PubMed]
  37. Van Wart, H.E.; Steinbrink, D.R. A continuous spectrophotometric assay for Clostridium histolyticum collagenase. Anal. Biochem. 1981, 113, 356–365. [Google Scholar] [CrossRef]
  38. Kraunsoe, J.A.E.; Claridge, T.D.W.; Lowe, G. Inhibition of human leukocyte and porcine pancreatic elastase by homologues of bovine pancreatic trypsin inhibitor. Biochemistry 1996, 35, 9090–9096. [Google Scholar] [CrossRef] [PubMed]
  39. Kim, J.H.; Byun, J.C.; Bandi, A.K.R.; Hyun, C.G.; Lee, N.H. Compounds with elastase inhibition and free radical scavenging activities from Callistemon lanceolatus. J. Med. Plant Res. 2009, 3, 914–920. [Google Scholar]
  40. Tadtong, S.; Viriyaroj, A.; Vorarat, S.; Nimkulrat, S.; Suksamrarn, S. Antityrosinase and antibacterial activities of mangosteen pericarp extract. J. Health Res. 2009, 23, 99–102. [Google Scholar]
  41. Sahgal, G.; Ramanathan, S.; Sasidharan, S.; Mordi, M.N.; Ismail, S.; Mansor, S.M. In vitro antioxidant and xanthine oxidase inhibitory activities of methanolic Swietenia mahagoni seed extracts. Molecules 2009, 14, 4476–4485. [Google Scholar] [CrossRef] [PubMed]
  42. Campos, P.M.; da Silva Horinouchi, C.D.; da Silveira Prudente, A.; Cechinel-Filho, V.; de Almeida Cabrini, D.; Otuki, M.F. Effect of a Garcinia gardneriana (Planchon and Triana) Zappi hydroalcoholic extract on melanogenesis in B16F10 melanoma cells. J. Ethopharmacol. 2013, 148, 199–204. [Google Scholar] [CrossRef] [PubMed]
  43. Yoon, N.Y.; Eom, T.K.; Kim, M.M.; Kim, S.K. Inhibitory effect of Phlorotannins isolated from Ecklonia cava on mushroom tyrosinase activity and melanin formation in mouse B16F10 melanoma cells. J. Agric. Food Chem. 2009, 57, 4124–4129. [Google Scholar] [CrossRef] [PubMed]
  44. Li, X.; Guo, L.; Sun, Y.; Zhou, J.; Gu, Y.; Li, Y. Baicalein inhibits melanogenesis through activation of the ERK signaling pathway. Int. J. Mol. Med. 2010, 25, 923–927. [Google Scholar] [CrossRef] [PubMed]
  • Sample Availability: Samples of tairin and shima EOs are available from the authors.

Share and Cite

MDPI and ACS Style

Tu, P.T.B.; Tawata, S. Anti-Oxidant, Anti-Aging, and Anti-Melanogenic Properties of the Essential Oils from Two Varieties of Alpinia zerumbet. Molecules 2015, 20, 16723-16740. https://doi.org/10.3390/molecules200916723

AMA Style

Tu PTB, Tawata S. Anti-Oxidant, Anti-Aging, and Anti-Melanogenic Properties of the Essential Oils from Two Varieties of Alpinia zerumbet. Molecules. 2015; 20(9):16723-16740. https://doi.org/10.3390/molecules200916723

Chicago/Turabian Style

Tu, Pham Thi Be, and Shinkichi Tawata. 2015. "Anti-Oxidant, Anti-Aging, and Anti-Melanogenic Properties of the Essential Oils from Two Varieties of Alpinia zerumbet" Molecules 20, no. 9: 16723-16740. https://doi.org/10.3390/molecules200916723

Article Metrics

Back to TopTop